Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lumasiran in Hyperoxalaemic Patients on Haemodialysis

NCT06225544 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT06225544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06225544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lumasiran in Hyperoxalaemic Patients on Haemodialysis
Lead sponsor
Charite University, Berlin, Germany
Phase
Phase 2
Overall status
Recruiting
Start date
April 14, 2024
Completion date
March 1, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, cardiovascular risk factor, chronic kidney disease requiring chronic dialysis, haemodialysis, hyperoxalemia